Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | BSN | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | FOXI3 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | UBR5 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | DACH1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | E2F3 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | CIC | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | CHADL | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | ZNF566 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | ZNF610 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |